Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy

View ORCID ProfileSumito Inoue, Akira Igarashi, Keita Morikane, Osamu Hachiya, Masafumi Watanabe, View ORCID ProfileSeiji Kakehata, Shinya Sato, View ORCID ProfileYoshiyuki Ueno
doi: https://doi.org/10.1101/2021.09.13.21263473
Sumito Inoue
1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University Faculty of Medicine, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sumito Inoue
  • For correspondence: sinoue@med.id.yamagata-u.ac.jp
Akira Igarashi
1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University Faculty of Medicine, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keita Morikane
2Division of Clinical Laboratory and Infection Control, Yamagata University Hospital, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osamu Hachiya
3Division of Infection Control, Yamagata University Hospital, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masafumi Watanabe
1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University Faculty of Medicine, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seiji Kakehata
4Department of Otolaryngology Head and Neck Surgery, Yamagata University Faculty of Medicine, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seiji Kakehata
Shinya Sato
5Yamagata University Hospital, Yamagata University Faculty of Medicine, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiyuki Ueno
6Department of Gastroenterology, Yamagata University Faculty of Medicine, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yoshiyuki Ueno
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) vaccination is progressing globally. Several adverse reactions have been reported with vaccination against COVID-19. It is unknown whether adverse reactions to COVID-19 vaccination are severe in individuals with allergies. We administered the COVID-19 vaccine to the medical staff at Yamagata University Hospital from March to August 2021. Subsequently, we conducted an online questionnaire-based survey to investigate the presence of allergy and adverse reactions after vaccination and examined the association between allergy and adverse reactions after immunization.

Responses were collected from 1586 subjects after the first vaccination and 1306 subjects after the second administration of the BNT162b2 mRNA COVID-19 vaccine. Adverse reactions included injection site pain, injection site swelling, fever, fatigue or malaise, headache, chills, nausea, muscle pain outside the injection site, and arthralgia. The frequency and severity of most adverse reactions were higher after the second vaccination compared to the first. The frequency of some adverse reactions and their severity were higher, and the duration of symptoms was longer in subjects with allergies than in subjects without allergies. Although several participants visited the emergency room for treatment after the first and second vaccinations, nobody was diagnosed with anaphylaxis.

Given the serious consequence of COVID-19 and the reported high efficacy of this vaccine against this disease, we conclude that vaccination of allergic individuals is generally recommended.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; SI has received lecture fees from Pfizer Japan Inc., and KYORIN Pharmaceutical Co.,Ltd. MW has received research grant and lecture fee from Pfizer Japan Inc. SS has received donation course for medical science and education from NISSIN PHARMACEUTICAL CO., LTD. no other relationships or activities that could appear to have influenced the submitted work.

Funding Statement

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; SI has received lecture fees from Pfizer Japan Inc., and KYORIN Pharmaceutical Co.,Ltd. MW has received research grant and lecture fee from Pfizer Japan Inc. SS has received donation course for medical science and education from NISSIN PHARMACEUTICAL CO., LTD. no other relationships or activities that could appear to have influenced the submitted work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Institutional Ethics Committee of the Yamagata University Faculty of Medicine

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; SI has received lecture fees from Pfizer Japan Inc., and KYORIN Pharmaceutical Co.,Ltd. MW has received research grant and lecture fee from Pfizer Japan Inc. SS has received donation course for medical science and education from NISSIN PHARMACEUTICAL CO., LTD. no other relationships or activities that could appear to have influenced the submitted work.

Data Availability

All data will not be made public in principle because some parts contain personal information of the subjects. For ethical reasons, data that is not suitable for public disclosure may be made available only upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy
Sumito Inoue, Akira Igarashi, Keita Morikane, Osamu Hachiya, Masafumi Watanabe, Seiji Kakehata, Shinya Sato, Yoshiyuki Ueno
medRxiv 2021.09.13.21263473; doi: https://doi.org/10.1101/2021.09.13.21263473
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy
Sumito Inoue, Akira Igarashi, Keita Morikane, Osamu Hachiya, Masafumi Watanabe, Seiji Kakehata, Shinya Sato, Yoshiyuki Ueno
medRxiv 2021.09.13.21263473; doi: https://doi.org/10.1101/2021.09.13.21263473

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10021)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4833)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)